ANTICOAGULANTS AND THROMBOLYTICS - RISKS AND BENEFITS

被引：8
|
作者：
GUIDRY, JR
RASCHKE, RA
MORKUNAS, AR
机构：
来源：
CRITICAL CARE CLINICS | 1991年 / 7卷 / 03期
关键词：
D O I：
10.1016/S0749-0704(18)30295-1
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：533 / 554
页数：22
相关论文
共 50 条
  • [31] BENEFITS AND RISKS
    不详
    NATURE, 1973, 246 (5427) : 9 - 10
  • [32] Risks and benefits
    Nature Nanotechnology, 2006, 1 : 151 - 151
  • [33] RISKS AND BENEFITS
    TIPPEE, B
    OIL & GAS JOURNAL, 1981, 79 (25) : 15 - 15
  • [34] Risks and benefits
    不详
    NATURE NANOTECHNOLOGY, 2006, 1 (03) : 151 - 151
  • [35] Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
    Shin, Jung-Im
    Secora, Alex
    Alexander, G. Caleb
    Inker, Lesley A.
    Coresh, Josef
    Chang, Alex R.
    Grams, Morgan E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (08): : 1144 - 1152
  • [36] Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
    Vinogradova, Yana
    Coupland, Carol
    Hill, Trevor
    Hippisley-Cox, Julia
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 362 : k2505
  • [37] New oral anticoagulants and risks in ENT
    Hollis, S.
    CLINICAL OTOLARYNGOLOGY, 2013, 38 (04) : 355 - 357
  • [38] ORAL ANTICOAGULANTS - RISKS OF COMBINED DRUGS
    DESCOTES, J
    LERY, N
    LYON PHARMACEUTIQUE, 1977, 28 (04): : 319 - 321
  • [39] Minimizing the Risks of Anticoagulants and Platelet Inhibitors
    Alexander, Karen P.
    Peterson, Eric D.
    CIRCULATION, 2010, 121 (17) : 1960 - 1970
  • [40] Placebos, Full Disclosure, and Trust: The Risks and Benefits of Disclosing Risks and Benefits
    Schwartz, Peter H.
    AMERICAN JOURNAL OF BIOETHICS, 2015, 15 (10): : 13 - 14
12345